In conclusion, this study confirms that heterozygous loss of function mutations in SOX2 cause anophthalmia and microphthalmia and represent approximately 10% of patients ascertained for anophthalmia and microphthalmia but may also be non-penetrant. This evidence concerns the gene SOX2 and microphthalmia.